TRVI Competitors & Alternatives
Compare Trevi Therapeutics Inc with similar stocks in the same industry
Biotechnology
TRVI
Main Stock$18.25
Tradestie Score
55
Market Cap
$1.14B
Analyst Upside
+43.5%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IMVT
Immunovant, Inc. Common Stock
|
$38.62
|
$2.85B | - | 51 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
|
$2.56B | 18.2 | 59 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$25.52
|
$2.44B | - | 48 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$59.04
|
$2.42B | - | 46 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$158.61
|
$2.41B | - | 51 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$35.50
|
$2.40B | - | 56 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$26.86
|
$2.37B | - | 57 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$134.09
|
$2.35B | - | 47 | Compare |
More TRVI Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry